A bill to launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes; to the Committee on Energy and Commerce.

H.R. 1862 — A bill to launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes; to the Committee on Energy and Commerce.

By Mr. BILBRAY (for himself, Ms. DeGette, Mr. Dent, Mr. Gerlach, Mr. Holt, Ms. Fudge, Mr. Butterfield, and Mr. Langevin), H3278 [12MY]

Cosponsors added, H3987 [2JN], H4366 [21JN], H6344 [21SE], H6673 [6OC], H8967 [14DE]